Back to results
US 2012/0238594 A1Published application
Azaspirodecanone compounds
AssigneeHoffmann-La Roche Inc.
InventorsDaniel Hunziker, Werner Neidhart
Life of this patent
Estimating the term…
Abstract
The invention provides novel compounds having the general formula (I) wherein R1 and R2 are as described herein, compositions including the compounds, their pharmaceutically acceptable salts and esters and methods of using the compounds.
Claims39
A compound according to formula (I),
- wherein
- R1 is selected from the group consisting of haloalkoxyalkyl, oxopyrrolydinylalkyl and oxopiperidinylalkyl;
- and
- R2 is substituted phenyl or substituted pyridinyl, wherein substituted phenyl and substituted pyridinyl are substituted with one to three substituents independently selected from the group consisting of haloalkyl, hydroxyhaloalkyl, alkoxy and haloalkoxy;
- or a pharmaceutically acceptable salt or ester thereof.
2 more elements
Dependencies are inferred from the claim text.